Etiological role of human papillomavirus infection for inverted papilloma of the bladder

Journal of Medical Virology

Volumn 83, Issue 2, 2011, Pages 277-285

  Shigehara, Kazuyoshi ^a   Sasagawa, Toshiyuki ^b   Doorbar, John ^c   Kawaguchi, Shohei ^a   Kobori, Yoshitomo ^d   Nakashima, Takao ^e   Shimamura, Masayoshi ^e   Maeda, Yuji ^a   Miyagi, Tohru ^a   Kitagawa, Yasuhide ^a   Kadono, Yoshifumi ^a   Konaka, Hiroyuki ^a   Mizokami, Atsushi ^a   Koh, Eitetsu ^a   Namiki, Mikio ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Human papillomavirus; In situ hybridization; Inverted papilloma; Mcm7; P16

Indexed keywords

PROTEIN E7; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; BLADDER PAPILLOMA; CLINICAL ARTICLE; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; VIRUS GENOME; WART VIRUS;

ADULT; AGED; CAPSID PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA REPLICATION; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMA, INVERTED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 78650387322     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21966     Document Type: Article

References (29)

1. Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B. 2005. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis 5: 102.
2. Brake T, Connor JP, Petereit DG, Lambert PF. 2003. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: Identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Cancer Res 63: 8173-8180.
3. Broussard JN, Tan PH, Epstein JI. 2004. Atypia in inverted urothelial papillomas: Pathology and prognostic significance. Hum Pathol 35: 1499-1504.
4. Chan KW, Wong KY, Srivastava G. 1997. Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: An evaluation by polymerase chain reaction. J Clin Pathol 50: 1018-1021.
5. Cheng CW, Chan LW, Chan CK, Ng CF, Cheung HY, Chan SY, Wong WS, To KF. 2005. Is surveillance necessary for inverted papilloma in the urinary bladder and urethra? ANZ J Surg 75: 213-217.
6. Cheon J, Kim HK, Kim JJ, Yoon DK, Koh SK, Kim IS. 1995. Malignant inverted papilloma of the urinary bladder: The histopathological aspect of malignant potential of inverted papilloma. J Korean Med Sci 10: 103-110.
7. Cooper K, Herrington CS, Stickland JE, Evans MF, McGee JO. 1991. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol 44: 990-996.
8. De Marchi Triglia R, Metze K, Zeferino LC, Lucci De Angelo Andrade LA. 2009. HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression. Gynecol Oncol 112: 114-118.
9. Doorbar J. 2006. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110: 525-541.
10. Hafkamp HC, Speel EJ, Haesevoets A, Bot FJ, Dinjens WN, Ramaekers FC, Hopman AH, Manni JJ. 2003. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 107: 394-400.
11. Kalof AN, Evans MF, Simmons-Arnold L, Beatty BG, Cooper K. 2005. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: Potential markers of high-grade cervical intraepithelial neoplasia. Am J Surg Pathol 29: 674-679.
12. Kamel D, Pääkkö P, Pöllänen R, Vähäkangas K, Lehto VP, Soini Y. 1995. Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS 103: 331-338.
13. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M. 2001. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276-284.
14. Krüger S, Mahnken A, Kausch I, Feller AC. 2005. P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma. Eur Urol 47: 463-467.
15. Lopez-Beltran A, Montironi R. 2004. Non-invasive urothelial neoplasms: According to the most recent WHO classification. Eur Urol 46: 170-176.
16. Moonen PM, Bakkers JM, Kiemeney LA, Schalken JA, Melchers WJ, Witjes JA. 2007. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 52: 464-468.
17. Niehans GA, Kratzke RA, Froberg MK, Aeppli DM, Nguyen PL, Geradts J. 1999. G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder. Br J Cancer 80: 1175-1184.
18. Potts IF, Hirst E. 1963. Inverted papilloma of the bladder. J Urol 90: 175-179.
19. Roberts S, Ashmole I, Rookes SM, Gallimore PH. 1997. Mutational analysis of the human papillomavirus type 16 E1-E4 protein shows that the C terminus is dispensable for keratin cytoskeleton association but is involved in inducing disruption of the keratin filaments. J Virol 71: 3554-3562.
20. Rocco JW, Sidransky D. 2001. P16 (MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264: 42-55.
21. Shai A, Brake T, Somoza C, Lambert PF. 2007. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res 67: 1626-1635.
22. Shigehara K, Sasagawa T, Kawaguchi S, Kobori Y, Nakashima T, Shimamura M, Taya T, Furubayashi K, Namiki M. 2010. Prevalence of human papillomavirus infection in the urinary tract of men with urethritis. Int J Urol 17: 563-569.
23. Sung MT, Maclennan GT, Lopez-Beltran A, Montironi R, Cheng L. 2006a. Natural history of urothelial inverted papilloma. Cancer 107: 2622-2627.
24. Sung MT, Eble JN, Wang M, Tan PH, Lopez-Beltran A, Cheng L. 2006b. Inverted papilloma of the urinary bladder: A molecular genetic appraisal. Mod Pathol 19: 1289-1294.
25. Tenti P, Zappatore R, Romagnoli S, Civardi E, Giunta P, Scelsi R, Stella G, Carnevali L. 1996. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: Correlation with histological parameters. J Pathol 178: 65-70.
26. Urakami S, Igawa M, Shirakawa H, Shiina H, Ishibe T. 1996. Biological characteristics of inverted papilloma of the urinary bladder. Br J Urol 77: 55-60.
27. Wang Q, Griffin H, Southern S, Jackson D, Martin A, McIntosh P, Davy C, Masterson PJ, Walker PA, Laskey P, Omary MB, Doorbar J. 2004. Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol 78: 821-833.
28. Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kiptoo M, Nakitare GW, Ichimura H, Inoue M. 2008. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol 80: 847-855.
29. Yang CC, Chu KC, Chen HY, Chen WC. 2002. Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression. Urol Int 69: 190-194.